Ranked above it
Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our NAD+ provider ranking, above Strut Health at #11.
Read the Care Bare Rx review →
Provider review
Strut Health cost: $325/mo tirzepatide
An FDA warning letter over labeling — and every price assumes auto-refill.
FDA's February 2026 letter cites Strut's own site for marketing compounded tirzepatide and semaglutide as "Generic Zepbound, Mounjaro." Separately, every sermorelin and tirzepatide page leads with an auto-refill price — and on the sermorelin side, the one-time price is never published in dollars at all.
Verified August 2026
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What Strut Health discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
At a glance
Visit Strut HealthPharmacy
Not categorized
Labs
Not stated anywhere
States
Published state list
On this page
What it actually costs
- Sermorelin$119/mo
- Tirzepatide$325/mo
- Semaglutide$149/mo
- NAD+Not published
What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not disclosed
Coaching
Not disclosed
The catch — Auto-refill enrollment. On tirzepatide, Strut discloses the gap on the same page — a separate option states the real one-time price. On sermorelin, no one-time price appears anywhere on the site; only the company blog admits a discount exists, without ever saying what it is discounted from.
See plans at Strut HealthPrices read from Strut Health's own site · August 2026
What they advertise
Every product page leads with an "Auto Refill" price: $199/mo "As low as, Save 14%" for injectable tirzepatide, $199/mo "Save 17%" for oral tirzepatide, $119/mo "Starting At, Save 18%" for injectable sermorelin, and $99/mo with no percentage at all for the oral sermorelin lozenge.
What you actually pay
Tirzepatide: $325/month injectable or $239/month oral, published on the same page as a separately priced "30 DAY SUPPLY" option — a stated figure, not a derived one. That same panel on both pages carries a line that reconciles with neither: "Just $6.63 to help accelerate your weight loss journey." $6.63 × 30 is $198.90 — not $325, not $239, but the auto-refill price printed higher up the page. Sermorelin: no one-time price is published in dollars for either format. Strut's blog says only that "all auto-refills are discounted by 21%," which doesn't match the 18% on the injectable product page. Semaglutide is $149 a month.
Money you will meet later
- Its Refund Policy — last modified September 21, 2021, nearly five years ago — says that once medication leaves the pharmacy, "we are unable to accept returns or offer refunds due to government regulations," and that a cancellation arriving after processing starts can't be refunded.
- You can cancel a subscription yourself from My Account, with 48 hours' notice before the next processing date.
The bottom line
Strut Health, LLC (Dallas, TX; founder and CEO Dr. Simal Patel, MD) sells compounded tirzepatide, injectable and oral, and compounded sermorelin, injectable and as an oral lozenge — the third provider here, after Fridays and EOS Health, to sell both boarded compounds directly. It ships to "all states except for Arkansas" per its FAQ, and its LegitScript seal checks out. Two things pull hard against it. First, FDA issued Strut Health, LLC a warning letter (MARCS-CMS 721448, February 20, 2026) after reviewing struthealth.com in December 2025. It cites product labels pictured on the site that put "Strut" on the vial as though Strut compounded the drugs — it doesn't — and marketing claims: "Generic Zepbound, Mounjaro," "Tirzepatide is the active ingredient in the brand medications Zepbound® and Mounjaro®." FDA says those falsely imply an FDA approval and safety review a compounded drug has never had, misbranding under FDCA §502(a) and §502(bb). Roughly five and a half months later, neither the quoted phrase nor a "Strut"-branded label appears on the product pages and images checked — the tirzepatide vial now reads only "TIRZEPATIDE / MEDICAL WEIGHT MANAGEMENT COMPOUNDED MEDICATION / PRESCRIPTION ONLY" — which looks like at least partial cleanup, though not every page and image on the site was checked. Second, every product page leads with an "Auto Refill" price dressed as "As low as" or "Starting at." On tirzepatide, Strut owns up on the same page: a one-time-purchase panel a few lines down puts the real 30-day price at $325 injectable or $239 oral — 39% and 20% above the $199 headline. On sermorelin, neither product page publishes a one-time price in dollars at all. Only the company blog admits an auto-refill discount exists, and the blanket "21%" it quotes doesn't match the "Save 18%" badge on the injectable sermorelin page.
Strut Health appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want one company for both compounded tirzepatide and compounded sermorelin, injectable and oral, instead of shopping two providers.
- You're needle-averse and want an oral option you can actually buy — Strut sells an oral tirzepatide tablet and an oral sermorelin lozenge, not a marketed placeholder.
- You've read FDA's warning letter against Strut's current site and are satisfied the flagged claims are gone from the pages you care about.
Look elsewhere if
- An open FDA warning letter over how a company marketed compounded drugs is a hard line for you, remediation or not.
- You're budgeting off "As low as $199" or "Starting at $99" — on tirzepatide the real one-time price is 20-39% higher, on the same page; on sermorelin there is no one-time price published at all.
- You want a pharmacy named, or a 503A/503B category — Strut names no pharmacy anywhere, the thinnest disclosure of any provider here.
What Strut Health offers
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Who fills your prescription
No category stated
Strut Health does not name the pharmacy that fills your prescription.
What its own site says
No pharmacy is named anywhere — not on the homepage, the FAQ, the Terms and Conditions, the Privacy Policy, the Telemedicine Consent, the Refund Policy, or either product page. That is the thinnest pharmacy disclosure of any provider here. Its Terms say, "Neither Strut nor Titan Medical Group endorses any specific medication, pharmacy, or pharmacologic product," naming Titan Medical Group as the separate clinical entity that writes the prescriptions; the Telemedicine Consent refers to an unnamed "Strut Health's partner pharmacy." Neither "503A" nor "503B" appears anywhere.
What's the difference between 503A and 503B?
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Where you can get it
Published state list
Near-nationwide, and published: the FAQ says, "As of September 2024, we can ship to all states except for Arkansas" — 49 states, one named exclusion, no further caveat. Strut dates that claim itself, to September 2024, which makes it nearly two years old.
The honest cons
The part they would rather you skipped
FDA issued Strut Health, LLC a warning letter (MARCS-CMS 721448, February 20, 2026, Center for Drug Evaluation and Research), addressed to "Simal Patel, MD, Chief Executive Officer, Strut Health, LLC dba Strut, 701 Commerce St, Dallas, TX 75202" — the same name, title and address struthealth.com publishes itself, so there is no doubt it is this company. FDA reviewed the site in December 2025 and found two things. One: "The compounded semaglutide and tirzepatide products displayed on your website identify 'Strut' on the pictured label, suggesting Strut is the compounder of those drugs when in fact it is not." Two: the site carried "Generic Zepbound, Mounjaro," "Semaglutide is the active ingredient in the brand medications," and "Tirzepatide is the active ingredient in the brand medications Zepbound® and Mounjaro®" — claims FDA says falsely imply an FDA approval and safety review a compounded drug has never had, misbranding under FDCA §502(a) and §502(bb) [21 U.S.C. §§ 352(a), 352(bb)]. Roughly five and a half months on, the current site shows neither the quoted "Generic Zepbound, Mounjaro" phrase nor a "Strut"-branded label on the injectable or oral tirzepatide pages, the injectable or oral sermorelin pages, or the compounded-tirzepatide FAQ post. The tirzepatide vial image now reads only "TIRZEPATIDE / MEDICAL WEIGHT MANAGEMENT COMPOUNDED MEDICATION / PRESCRIPTION ONLY," with no brand name on it, and the page's small print says correctly, "Compounded medications are not FDA-approved and have not gone through FDA safety and efficacy review." That looks like real cleanup — but not every page and image on the site was checked, so this stays a dated regulatory finding, not a declaration that the problem is fixed everywhere.
- An FDA warning letter (MARCS-CMS 721448, Feb 20, 2026) over compounded-drug labeling and marketing claims — the knock above has it in full.
- The advertised auto-refill price isn't the standing price on either line: tirzepatide's one-time rate ($325 injectable, $239 oral) runs 20-39% above the $199 headline, and sermorelin's is never published in dollars at all.
- Its blog quotes a blanket "21%" auto-refill discount for sermorelin that doesn't match the "Save 18%" badge on the injectable sermorelin page.
- No pharmacy is named anywhere, and no 503A/503B category is stated for any product — the thinnest disclosure of any provider here.
- No dietitian, nurse, or coaching program is named anywhere on the site.
None of this is unique to Strut Health — the whole category shares it.
How it compares
The providers we rank on our NAD+ provider ranking — the most specific board Strut Health sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- Care Bare RxTells you exactly what you're buying — but $199 is a starting point, not a rate.
- Enhance MDHonest pricing and a real 503A claim — but it isn't in all 50 states, whatever it says.
- Breeze MedsNames the exact compound in its nav — then hides the price behind a quiz.
- Sprout HealthNames both pharmacies and a real 44-state list — but every price is a starting floor.
- EdenA named pharmacy, but a hidden membership fee nearly doubles the real price.
- CoreAge RxOne price per compound that covers every dose — and no pharmacy named on the site.
- EmbodyA "SAVE $100" badge on its purchase page is wrong — the real discount is $220.
- LttlCalls its pricing "Priced Honestly" — the headline rate needs a year paid upfront.
45 more providers rank on our NAD+ provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Strut Health's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect Strut Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Strut Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Strut Health
4 compounds from $119/mo